Jefferies Financial Group’s United Therapeutics UTHR Stock Holding History

Jefferies Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.63M	Buy	6,697 +696	+12%	+$392K	0.02%	475
2026 Q1	$3.56M	Sell	6,001 -3,148	-34%	-$1.57M	0.02%	423
2025 Q4	$4.46M	Buy	+9,149	New	+$4.26M	0.02%	522
2024 Q3	–	Sell	-5,700	Closed	-$1.82M	–	1788
2024 Q2	$1.82M	Sell	5,700 -4,300	-43%	-$1.14M	0.02%	564
2024 Q1	$2.3M	Sell	10,000 -385	-4%	-$86.9K	0.02%	544
2023 Q4	$2.28M	Buy	+10,385	New	+$2.39M	0.01%	661
2023 Q2	–	Sell	-1,440	Closed	-$323K	–	2025
2023 Q1	$323K	Buy	+1,440	New	+$355K	﹤0.01%	1213

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Jefferies Financial Group's UTHR Position: Q2 2026 in Review

Jefferies Financial Group increased its United Therapeutics (UTHR) stake by 12% in Q2 2026, buying an estimated $392K and bringing the position to 6,697 shares worth $3.63M. The position accounts for 0.02% of the portfolio, ranked #475.

Jefferies Financial Group first reported a position in UTHR in Q1 2023 and has held it in 7 quarters since. The position peaked at $4.46M in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Jefferies Financial Group held 6,697 shares of United Therapeutics worth $3.63M as of Q2 2026.
Jefferies Financial Group bought 696 United Therapeutics shares in Q2 2026, an estimated $392K.
United Therapeutics made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #475 holding.
Jefferies Financial Group first reported a position in United Therapeutics in Q1 2023 and has held it in 7 quarters since.
Jefferies Financial Group's United Therapeutics position peaked at $4.46M in Q4 2025.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.